Utilization frequency and patient-reported effectiveness of symptomatic therapies in post-COVID syndrome

Miriam Reuner,Johannes Krehbiel,Jürgen Rech,Brigitte Greiner,Isabel Schäfer,Regina Herold,Eva Morawa,Yesim Erim
DOI: https://doi.org/10.1186/s12889-024-19951-3
IF: 4.5
2024-09-26
BMC Public Health
Abstract:To date there is no causal treatment for post-COVID syndrome, leaving symptomatic treatments as the primary recourse. However, the practical implementation and effectiveness of these interventions remain underexplored. This study aimed to investigate the utilization frequency of symptomatic therapies and patient-reported effectiveness across various treatment modalities at a German post-COVID center.
public, environmental & occupational health
What problem does this paper attempt to address?